Text size A A

Section Menu

Investors

Upcoming Events

CVS Caremark Corporation at Credit Suisse Healthcare Conference
Date	11-12-2009

CVS Caremark Corporation at Lazard Capital Healthcare Conference
Date	11-17-2009

Archived Events

Q3 2009 CVS Caremark Corporation Earnings Conference Call

11/5/2009 8:30 AM ET

Investor Quick Links

Officers & Directors
Interactive Investor Kit
Investor FAQs
SEC Filings
Financial Tear Sheet
Information Request Form
Email Alerts

Facts by State

Better Investing

CVS Caremark is a Corporate Member of Better Investing (formerly NAIC) and participates in its Low-Cost Investment Plan. To receive more information on Better Investing, call (248) 583-NAIC or visit their website by clicking here.

CVS Caremark is the only fully integrated pharmacy health care company in the United States. Our offerings across the entire spectrum of pharmacy care allow us to provide greater convenience and choice for patients, improve health outcomes, and lower overall health care costs for plan sponsors and participants. As one of the country’s largest pharmacy benefit managers (PBMs), we provide plan sponsors and participants access to a network of approximately 60,000 pharmacies including over 7,000 CVS/pharmacy stores. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and our clinical expertise includes one of the industry’s most comprehensive disease management programs. We are also a leading provider of Medicare Part D Prescription Drug Plans.Learn more

Recent news

11-05-2009
David Denton to Become CVS Caremark Chief Financial Officer

Denton replaces David Rickard who retires at year end Laird Daniels named Controller and Chief Accounting Officer WOONSOCKET, R.I.--(BUSINESS WIRE)--Nov. 5, 2009-- CVS Caremark (NYSE: CVS) today announced the appointment of David M. Denton to the new role of Executive Vice President and Chief Financial Officer, effective January 1, 2010. Denton will succeed David Rickard who announced in February of this year his intention to retire a

11-05-2009
CVS Caremark Corporation Announces New Authorization of Repurchase Program for up to $2 Billion of Common Stock

WOONSOCKET, R.I.--(BUSINESS WIRE)--Nov. 5, 2009-- CVS Caremark Corporation (NYSE: CVS) today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately

11-05-2009
CVS Caremark Reports Record Third Quarter 2009 Results

Third Quarter Year-Over-Year Highlights: Adjusted EPS from continuing operations of $0.65 (excluding an $0.11 income tax benefit), up 8.1% GAAP diluted EPS from continuing operations of $0.71 (including an $0.11 income tax benefit) Net revenues of $24.6 billion, up 18.1% PBM revenues increased 23.4%, with pharmacy network revenues up 28.3% while mail choice reven

View All

Latest Financials & Reports

Form 10-Q Q309
CEO/CFO Statements Q309
Non-GAAP Disclosures Q309
Reg G - Business Segment Changes Q309
Business Segment Schedules Q309
Supplemental Information Q309 - Rev
2008 Annual Report
2009 Proxy Statement
2008 Form 10-K
2008 Corporate Social Responsibility Report

Most Recent Annual Report